CTRI/2018/12/016696RecruitingPhase 1
Impact of combo herbal supplement intervention on hypoglycemic effect in Type 1 diabetic children: A randomized controlled trial.
Sukhjindar Singh Ghotra0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Aged between 4- 14 years.
- •Diabetic Children with Type 1 Diabetes.
- •Physician approval for selected patient.
- •Parentâ??s willingness to provide informed consent. Diabetes diagnosed for at least 6 months.
Exclusion Criteria
- •Any preexisting condition / contraindications (abnormal creatinine levels, liver dysfunction).
- •Patients due for operations.
- •Enrolled in other active intervention research studies.
Investigators
Similar Trials
Not yet recruiting
Not Applicable
A clinical trial investigating the impact of a herbal supplement on sleep in individuals with insomnia symptomsAlternative and Complementary Medicine - Herbal remediesNeurological - Other neurological disordersInsomniaACTRN12621000733875Melrose Health40
Recruiting
Phase 3
Comparison of the effect of combined herbal medicine with routine medicine on sperm quality and chromatine integrity in oligoasthenoteratozoospermia meMale infertilityIRCT20200929048878N1Iranian academic center for education culture and research50
Not yet recruiting
Not Applicable
The Effect of Co-administration of Herbal extracts to Sorafenib (NexavarTM) on the QoL in patients with Hepatocellular carcinoma - pilot studyKCT0001354Comprehensive and Integrative Medical Institute16
Not yet recruiting
Not Applicable
Evaluation of the effect of herbal combination of fenugreek seeds and carrot seeds on sexual function 0fwomen with diabetes type 2,a randomized double-blinded clinical trialIRCT20210222050457N2Yazd University of Medical Sciences100
Completed
Phase 2
Evaluating the effect of herbal supplement capsule on treatment of peptic disease patientsGastric ulcerIRCT20151230025772N10Zojaj Darman Toos pharmaceutical company70